Dependence of NPPS creates a targetable vulnerability in RAS-mutant cancers
Acta Pharmacol Sin. 2024 Nov 6. doi: 10.1038/s41401-024-01409-2. Online ahead of print. ABSTRACT RAS is the most frequently mutated oncoprotein for cancer driving. Understanding of …